C4 Therapeutics to Participate in Upcoming March Investor Conferences
C4 Therapeutics (Nasdaq: CCCC), a clinical-stage biopharmaceutical company focused on targeted protein degradation science, has announced its participation in two major investor conferences in March 2025.
The company will present at the TD Cowen 45th Annual Healthcare Conference on March 3rd at 9:10 am ET in Boston, MA. A live webcast will be accessible through the company's website's Events & Presentations page, with replay available for approximately 30 days after the event.
Additionally, management will attend the Leerink Partners Global Healthcare Conference on March 9th in Miami, FL.
C4 Therapeutics (Nasdaq: CCCC), un'azienda biofarmaceutica in fase clinica focalizzata sulla scienza della degradazione mirata delle proteine, ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo 2025.
L'azienda presenterà al TD Cowen 45° Annual Healthcare Conference il 3 marzo alle 9:10 ET a Boston, MA. Una diretta streaming sarà accessibile tramite la pagina Eventi e Presentazioni del sito web dell'azienda, con un replay disponibile per circa 30 giorni dopo l'evento.
Inoltre, la direzione parteciperà al Leerink Partners Global Healthcare Conference il 9 marzo a Miami, FL.
C4 Therapeutics (Nasdaq: CCCC), una empresa biofarmacéutica en etapa clínica centrada en la ciencia de la degradación de proteínas dirigida, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025.
La empresa presentará en la TD Cowen 45ª Conferencia Anual de Salud el 3 de marzo a las 9:10 am ET en Boston, MA. Se podrá acceder a una transmisión en vivo a través de la página de Eventos y Presentaciones del sitio web de la empresa, con una repetición disponible durante aproximadamente 30 días después del evento.
Además, la dirección asistirá a la Leerink Partners Global Healthcare Conference el 9 de marzo en Miami, FL.
C4 Therapeutics (Nasdaq: CCCC), 표적 단백질 분해 과학에 중점을 둔 임상 단계의 생물 제약 회사가 2025년 3월에 두 개의 주요 투자자 회의에 참여한다고 발표했습니다.
회사는 3월 3일 오전 9시 10분 ET에 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 의료 회의에서 발표할 예정입니다. 회사 웹사이트의 이벤트 및 발표 페이지를 통해 생중계가 제공되며, 이벤트 후 약 30일 동안 다시 보기 서비스가 제공됩니다.
또한 경영진은 3월 9일 플로리다주 마이애미에서 열리는 Leerink Partners 글로벌 의료 회의에 참석할 예정입니다.
C4 Therapeutics (Nasdaq: CCCC), une entreprise biopharmaceutique en phase clinique axée sur la science de la dégradation ciblée des protéines, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025.
L'entreprise présentera à la TD Cowen 45e Conférence Annuelle sur la Santé le 3 mars à 9h10 ET à Boston, MA. Une diffusion en direct sera accessible via la page Événements et Présentations du site web de l'entreprise, avec une rediffusion disponible pendant environ 30 jours après l'événement.
De plus, la direction assistera à la Leerink Partners Global Healthcare Conference le 9 mars à Miami, FL.
C4 Therapeutics (Nasdaq: CCCC), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Wissenschaft der gezielten Proteinabbau konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 bekannt gegeben.
Das Unternehmen wird am 3. März um 9:10 Uhr ET in Boston, MA, auf der TD Cowen 45. jährlichen Gesundheitskonferenz präsentieren. Ein Live-Stream wird über die Seite Veranstaltungen & Präsentationen der Unternehmenswebsite zugänglich sein, mit einer Wiederholung, die etwa 30 Tage nach der Veranstaltung verfügbar ist.
Darüber hinaus wird das Management an der Leerink Partners Global Healthcare Conference am 9. März in Miami, FL, teilnehmen.
- None.
- None.
WATERTOWN, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in two upcoming March investor conferences.
- TD Cowen 45th Annual Healthcare Conference:
- Management will present on March 3rd at 9:10 am ET in Boston, MA. The live webcast will be available on the Events & Presentations page of the company’s website. The archived replay of the webcast will be available for approximately 30 days following the live event.
- Leerink Partners Global Healthcare Conference:
- Management will participate in the conference on March 9th in Miami, FL.
About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.
Contacts:
Investors:
Courtney Solberg
Senior Manager, Investor Relations
CSolberg@c4therapeutics.com
Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com
FAQ
When is C4 Therapeutics (CCCC) presenting at the TD Cowen Healthcare Conference in March 2025?
How long will the CCCC TD Cowen conference webcast be available for replay?
Which investor conferences is C4 Therapeutics (CCCC) attending in March 2025?
Where can investors access the CCCC TD Cowen conference presentation webcast?
